Revance Therapeutics, Inc. Quarterly Common Stock, Shares, Issued from Q4 2013 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Revance Therapeutics, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2013 to Q2 2024.
  • Revance Therapeutics, Inc. Common Stock, Shares, Issued for the quarter ending June 30, 2024 was 105M shares, a 19.2% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 105M +16.9M +19.2% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 104M +20.4M +24.3% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 88M +5.58M +6.77% Dec 31, 2023 10-Q 2024-08-08
Q3 2023 87.8M +5.53M +6.72% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 87.9M +14.8M +20.3% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 84M +12.3M +17.1% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 82.4M +10.8M +15.1% Dec 31, 2022 10-K 2024-02-28
Q3 2022 82.3M +10.4M +14.5% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 73.1M +1.32M +1.85% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 71.8M +352K +0.49% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 71.6M +2.41M +3.48% Dec 31, 2021 10-K 2023-02-28
Q3 2021 71.8M +5.25M +7.89% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 71.8M +14.5M +25.3% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 71.4M +14.4M +25.2% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 69.2M +16.8M +32.1% Dec 31, 2020 10-K 2022-02-28
Q3 2020 66.6M +22.5M +51% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 57.3M +13.2M +29.9% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 57M +13M +29.6% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 52.4M +15.4M +41.6% Dec 31, 2019 10-K 2021-02-25
Q3 2019 44.1M +7.12M +19.2% Sep 30, 2019 10-Q 2019-11-04
Q2 2019 44.1M +7.19M +19.5% Jun 30, 2019 10-Q 2019-08-06
Q1 2019 44M +7.26M +19.8% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 37M +459K +1.26% Dec 31, 2018 10-K 2020-02-26
Q3 2018 37M +6.06M +19.6% Sep 30, 2018 10-Q 2018-11-02
Q2 2018 36.9M +6.5M +21.4% Jun 30, 2018 10-Q 2018-08-03
Q1 2018 36.7M +6.61M +22% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 36.5M +7.87M +27.5% Dec 31, 2017 10-K 2019-02-28
Q3 2017 30.9M +2.42M +8.49% Sep 30, 2017 10-Q 2017-11-03
Q2 2017 30.4M +1.93M +6.79% Jun 30, 2017 10-Q 2017-08-04
Q1 2017 30.1M +30.1M Mar 31, 2017 10-Q 2017-05-09
Q4 2016 28.6M +360K +1.27% Dec 31, 2016 10-K 2018-03-02
Q3 2016 28.5M +4.2M +17.3% Sep 30, 2016 10-Q 2016-11-04
Q2 2016 28.5M +4.54M +18.9% Jun 30, 2016 10-Q 2016-08-05
Q1 2016 0 -23.9M -100% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 28.3M +4.51M +19% Dec 31, 2015 10-K 2017-02-28
Q3 2015 24.3M +595K +2.51% Sep 30, 2015 10-Q 2015-11-10
Q2 2015 23.9M +452K +1.93% Jun 30, 2015 10-Q 2015-08-07
Q1 2015 23.9M +5.29M +28.4% Mar 31, 2015 10-Q 2015-05-14
Q4 2014 23.8M +23.5M +9016% Dec 31, 2014 10-K 2016-03-04
Q3 2014 23.7M Sep 30, 2014 10-Q 2014-11-13
Q2 2014 23.5M Jun 30, 2014 10-Q 2014-08-13
Q1 2014 18.7M Mar 31, 2014 10-Q 2014-05-14
Q4 2013 261K Dec 31, 2013 10-K 2015-03-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.